HIV (Human Immunodeficiency Virus)NCT07468487
Evaluation of the Effectiveness of the HPV Education Program Applied to Women
A study testing Reproductive health education program in people with HIV (Human Immunodeficiency Virus), run by Okan University at 1 site in Turkey (Türkiye).
Trial summary
This study aimed to evaluate the effectiveness of an educational program conducted by nurses on Human Papilloma Virus and its effects on women's health in women of reproductive age. Read more about this study
- Who is it for?
- Ages 18 to 49 years, women only
- Conditions the study is for
- HIV (Human Immunodeficiency Virus)
- What is being tested?
- Reproductive health education program
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 84 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 25 Mar 2024to 14 Jan 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 49 years
- Women only
- No healthy volunteers
- Adult
Sampling Inclusion Criteria:
Female individuals Having been diagnosed with HIV Being between 18-49 years of age Being sexually active
Sampling Exclusion Criteria:
- Being pregnant
- Being postpartum
- Disabled individuals
- Individuals whose gender identity does not match their biological sex at birth, those receiving hormonal therapy, or other conditions that do not fit the specific biological focus of the study.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Istanbul Okan University
Tuzla, Istanbul, 34843
About this study
Official title: Evaluation of the Effectiveness of a Nursing Education Program on "HPV and Its Effects on Women's Health" Applied to Women of Reproductive Age
This study aimed to evaluate the effectiveness of an educational program conducted by nurses on Human Papilloma Virus and its effects on women's health in women of reproductive age. Data were collected from women aged 30-49 with active sexual lives using a Descriptive Information Form and the HPV Knowledge Scale, and then analyzed and interpreted.
Read the detailed description
This study used randomized experimental and control groups in its design. Participants were women with active sexual lives who visited a Family Health Center in Istanbul for three months. Sample size was determined using power analysis. Women in the experimental group participated in a nursing education program titled "HPV and its Effects on Women's Health." Written informed consent was obtained from the participants. A pre-test was administered to all participants. Following the baseline assessment, participants in the experimental group participated in a nurse-led education program prepared by the researcher. The program focused on HPV transmission, prevention methods, vaccination, screening, and its effects on women's health. Participants in the control group did not receive any educational intervention at this stage. One month after the completion of the training, post-tests were administered to both groups. The assessment tools used were as follows: Women's sociodemographic characteristics, participation in health screenings, and HPV-related characteristics were recorded on an Information Form. Women's knowledge level about HPV was measured using the HPV Knowledge Scale. The scale consisted of 33 items and 2 sub-dimensions. The first sub-dimension of the scale is scored between 0 and 16. Higher scores indicate a higher level of general knowledge about HPV. The second subdimension measures the level of knowledge about the HPV vaccination program. The total score obtainable from this subdimension ranges from 0 to 6. Higher scores indicate a higher level of knowledge about HPV vaccination.
- Conditions
- HIV (Human Immunodeficiency Virus)
- Being tested
- Reproductive health education program
- Keywords
- HIV, education, Health Promotion Model, Reproductive Health
- Medical subject headings
- Acquired Immunodeficiency Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Reproductive health education programBehavioural
Reproductive health education program prepared using Pender's Health Promotion Model.
| Study group | Role | What they receive |
|---|---|---|
| Education Group | Experimental | This group will be trained using Pender's Health Promotion Model. Receives: Behavioral: Reproductive health education program |
| Control | No intervention | This group will not receive training; only assessments will be conducted. |
What is being measured
The primary outcome is the main question the study is designed to answer.
"Scale for Determining the Reproductive Health Preventive Attitudes of Married Women"
The Reproductive Health Protective Attitudes Scale for Married Women is a Likert-type scale consisting of 39 items, scored from 1 to 5. The total raw score obtained by summing the 39 items ranges from 39 to 195. It has five sub-dimensions. Higher total and sub-dimension scores indicate more positive attitudes and behaviors towards protecting women's reproductive health.
Measured: Up to 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Mar 2026
- Study start25 Mar 2024
- Primary completion25 Sep 2024
- Study completion14 Jan 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HIV (Human Immunodeficiency Virus)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Our study will be conducted using an "Experimental Group" that will receive training and a "Control Group" that will not receive any training.
- Masking
- None (open label)
- Enrolment
- 84 participants (actual)
Sponsor and investigators
- Lead sponsor
- Okan University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Özlem Akgöl, Okan University
- Investigators
- Ozlem Akgol, Asst. Professor, Principal investigator, Okan University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07468487
- Sponsor's protocol ID
- 10.01.2024/172
- Status last verified
- Mar 2026
- First submitted
- 13 Feb 2026
- Last updated
- 17 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of the Effectiveness of a Nursing Education Program on "HPV and Its Effects on Women's Health" Applied to Women of Reproductive Age
- ClinicalTrials.gov ID
- NCT07468487
- Acronym / sponsor ID
- 10.01.2024/172
- Conditions
- HIV (Human Immunodeficiency Virus)
- Keywords
- HIV, education, Health Promotion Model, Reproductive Health
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 84 participants (actual)
- Lead sponsor
- Okan UniversityUniversity, hospital or other
- Study start
- 25 Mar 2024 (actual)
- Primary completion
- 25 Sep 2024 (actual)
- Study completion
- 14 Jan 2025 (actual)
- First posted
- 12 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aimed to evaluate the effectiveness of an educational program conducted by nurses on Human Papilloma Virus and its effects on women's health in women of reproductive age. Data were collected from women aged 30-49 with active sexual lives using a Descriptive Information Form and the HPV Knowledge Scale, and then analyzed and interpreted.
Detailed description
This study used randomized experimental and control groups in its design. Participants were women with active sexual lives who visited a Family Health Center in Istanbul for three months. Sample size was determined using power analysis. Women in the experimental group participated in a nursing education program titled "HPV and its Effects on Women's Health." Written informed consent was obtained from the participants. A pre-test was administered to all participants. Following the baseline assessment, participants in the experimental group participated in a nurse-led education program prepared by the researcher. The program focused on HPV transmission, prevention methods, vaccination, screening, and its effects on women's health. Participants in the control group did not receive any educational intervention at this stage. One month after the completion of the training, post-tests were administered to both groups. The assessment tools used were as follows: Women's sociodemographic characteristics, participation in health screenings, and HPV-related characteristics were recorded on an Information Form. Women's knowledge level about HPV was measured using the HPV Knowledge Scale. The scale consisted of 33 items and 2 sub-dimensions. The first sub-dimension of the scale is scored between 0 and 16. Higher scores indicate a higher level of general knowledge about HPV. The second subdimension measures the level of knowledge about the HPV vaccination program. The total score obtainable from this subdimension ranges from 0 to 6. Higher scores indicate a higher level of knowledge about HPV vaccination.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Our study will be conducted using an "Experimental Group" that will receive training and a "Control Group" that will not receive any training.
| Arm | Type | Receives |
|---|---|---|
| Education Group | Experimental | Behavioral: Reproductive health education programThis group will be trained using Pender's Health Promotion Model. |
| Control | No intervention | –This group will not receive training; only assessments will be conducted. |
Who may qualify
- Ages
- 18 to 49 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Reproductive health education programReproductive health education program prepared using Pender's Health Promotion Model. | Behavioural | Education Group |
Primary outcome
"Scale for Determining the Reproductive Health Preventive Attitudes of Married Women"
Time frame: Up to 6 months
The Reproductive Health Protective Attitudes Scale for Married Women is a Likert-type scale consisting of 39 items, scored from 1 to 5. The total raw score obtained by summing the 39 items ranges from 39 to 195. It has five sub-dimensions. Higher total and sub-dimension scores indicate more positive attitudes and behaviors towards protecting women's reproductive health.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Mar 2026.
Related trials for HIV (Human Immunodeficiency Virus)
Not yet recruiting
HealthMpowerment Korea: Pilot Testing the Cultural Adaptation of a Digital HIV Intervention for Men Who Have Sex With Men in South Korea
HIV Infections, HIV Prevention and Care
Not yet recruiting
Prescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use Support
People Who Use Opioids/People With Opioid Use Disorder (OUD)
Recruiting
Evaluating the Impact of Using the B-OK Bottles for HIV and ART Literacy in South Africa
HIV, HIV Treatment
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
RecruitingObservational study
Olfactory Function and Model-Based Behavior in People Living With HIV and SUD
HIV, Substance Use Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ozlem Akgol, Asst. Professor principal investigator
Okan University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Reproductive health education program in people with HIV (Human Immunodeficiency Virus), run by Okan University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
"Scale for Determining the Reproductive Health Preventive Attitudes of Married Women" (time frame: Up to 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Mar 2026.